A scoping study on future options for funding health was commissioned by the Three Diseases Fund (3DF) donors in March 2010. The scoping study recommended the following:

(i) There is value in continuing to provide joint support to address the basic health needs of the most vulnerable population of Myanmar, and
(ii) The next phase of the support should have a broader scope and address the three health MDGs.

2 March 2010 - The Ministry of Health has welcomed US$3million of assistance provided by the Three Diseases Fund (3DF) through the World Health Organization for the provision of anti-TB drugs to help the fight against tuberculosis, one of the priority diseases in Myanmar.

“With continuing support of donors, the Three Diseases Fund has been supporting the National Tuberculosis Programme since 2006 and allocated US$900,000 for anti-TB drugs in 2008 and 2009” said Mr. Philippe Allen, Chair of the Three Diseases Fund Board.

The Three Diseases Fund (3DF) aims to reduce the burden of communicable disease mortality and morbidity for Tuberculosis (TB), Malaria and HIV and AIDS in Burma/Myanmar.

You are a beneficiary of a health service provided with financial support from the Three Diseases Fund or working with beneficiaries at grassroots level. As part of our commitment to improve our support to a diversity of international NGOs, UN agencies, independent local and community-based organizations and the services they provide to beneficiaries, your opinion is important to us.

The information collated from this feedback mechanism will be confidential and acted upon within the fund management as part of our continuous improvement efforts.